Ayala Pharmaceuticals, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Ayala Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q4 2023.
  • Ayala Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2023 was -$24.7M, a 153% decline year-over-year.
  • Ayala Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2023 was -$48.1M, a 26.5% decline year-over-year.
  • Ayala Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$48.1M, a 26.5% decline from 2022.
  • Ayala Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$38M, a 113% decline from 2021.
  • Ayala Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$17.9M, a 32.5% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 -$48.1M -$24.7M -$14.9M -153% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-16
Q3 2023 -$33.2M -$7.34M +$2.85M +27.9% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-20
Q2 2023 -$36M -$8.7M -$591K -7.29% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 -$35.4M -$7.36M +$2.59M +26% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-23
Q4 2022 -$38M -$9.77M -$9.4M -2576% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-16
Q3 2022 -$28.6M -$10.2M -$4.74M -87.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-20
Q2 2022 -$23.9M -$8.11M -$4.77M -143% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$19.1M -$9.95M -$4.85M -94.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-23
Q4 2021 -$14.3M -$365K +$3.61M +90.8% Nov 1, 2021 Jan 31, 2022 10-Q 2022-09-13
Q3 2021 -$17.9M -$5.44M +$1.02M +15.7% Aug 1, 2021 Oct 31, 2021 10-K 2023-02-10
Q2 2021 -$18.9M -$3.33M +$2.5M +42.8% May 1, 2021 Jul 31, 2021 10-Q 2022-09-13
Q1 2021 -$21.4M -$5.11M +$1.22M +19.2% Feb 1, 2021 Apr 30, 2021 10-Q 2022-09-13
Q4 2020 -$22.6M -$3.98M +$3.88M +49.4% Nov 1, 2020 Jan 31, 2021 10-Q 2022-09-13
Q3 2020 -$26.5M -$6.46M +$3.73M +36.6% Aug 1, 2020 Oct 31, 2020 10-K 2022-02-14
Q2 2020 -$30.2M -$5.83M +$4.03M +40.9% May 1, 2020 Jul 31, 2020 10-Q 2021-09-10
Q1 2020 -$34.2M -$6.32M +$3.06M +32.6% Feb 1, 2020 Apr 30, 2020 10-Q 2021-09-10
Q4 2019 -$37.3M -$7.86M -$20.7M -161% Nov 1, 2019 Jan 31, 2020 10-Q 2021-09-10
Q3 2019 -$16.6M -$10.2M +$8.41M +45.2% Aug 1, 2019 Oct 31, 2019 10-K 2021-01-22
Q2 2019 -$25M -$9.86M +$4.16M +29.7% May 1, 2019 Jul 31, 2019 10-Q 2020-09-10
Q1 2019 -$29.2M -$9.38M +$4.02M +30% Feb 1, 2019 Apr 30, 2019 10-Q 2020-09-10
Q4 2018 -$33.2M $12.8M +$33.3M Nov 1, 2018 Jan 31, 2019 10-Q 2020-09-10
Q3 2018 -$66.5M -$18.6M +$4.66M +20% Aug 1, 2018 Oct 31, 2018 10-K 2019-12-20
Q2 2018 -$71.2M -$14M +$18.6M +57% May 1, 2018 Jul 31, 2018 10-Q 2019-09-09
Q1 2018 -$89.8M -$13.4M +$7.06M +34.5% Feb 1, 2018 Apr 30, 2018 10-Q 2019-09-09
Q4 2017 -$96.8M -$20.5M -$3.41M -20% Nov 1, 2017 Jan 31, 2018 10-Q 2019-09-09
Q3 2017 -$93.4M -$23.3M -$1.56M -7.18% Aug 1, 2017 Oct 31, 2017 10-K 2019-01-11
Q2 2017 -$91.9M -$32.6M -$16.1M -97.9% May 1, 2017 Jul 31, 2017 10-Q 2018-09-10
Q1 2017 -$75.7M -$20.5M -$4.95M -31.9% Feb 1, 2017 Apr 30, 2017 10-Q 2018-06-07
Q4 2016 -$70.8M -$17.1M +$2.76M +13.9% Nov 1, 2016 Jan 31, 2017 10-Q 2018-03-12
Q3 2016 -$73.6M -$21.7M -$9.12M -72.5% Aug 1, 2016 Oct 31, 2016 10-K 2017-12-21
Q2 2016 -$64.4M -$16.5M -$2.92M -21.6% May 1, 2016 Jul 31, 2016 10-Q 2017-09-11
Q1 2016 -$61.5M -$15.5M -$1.67M -12% Feb 1, 2016 Apr 30, 2016 10-Q 2017-06-06
Q4 2015 -$59.8M -$19.8M -$12.8M -182% Nov 1, 2015 Jan 31, 2016 10-Q 2017-03-10
Q3 2015 -$47M -$12.6M -$9.34M -288% Aug 1, 2015 Oct 31, 2015 10-K 2017-12-21
Q2 2015 -$37.7M -$13.6M -$7.78M -135% May 1, 2015 Jul 31, 2015 10-Q 2016-09-08
Q1 2015 -$29.9M -$13.9M -$11.5M -499% Feb 1, 2015 Apr 30, 2015 10-Q 2016-06-08
Q4 2014 -$18.4M -$7.03M -$1.85M -35.6% Nov 1, 2014 Jan 31, 2015 10-Q 2016-02-26
Q3 2014 -$16.5M -$3.24M +$4.16M +56.2% Aug 1, 2014 Oct 31, 2014 10-K 2017-01-09
Q2 2014 -$20.7M -$5.78M -$4.18M -262% May 1, 2014 Jul 31, 2014 10-Q 2015-09-11
Q1 2014 -$16.5M -$2.31M +$2.96M +56.1% Feb 1, 2014 Apr 30, 2014 10-Q 2015-06-15
Q4 2013 -$19.5M -$5.19M +$521K +9.12% Nov 1, 2013 Jan 31, 2014 10-Q 2015-03-13
Q3 2013 -$20M -$7.41M -$5.42M -272% Aug 1, 2013 Oct 31, 2013 10-K 2015-01-06
Q2 2013 -$14.6M -$1.6M +$1.51M +48.6% May 1, 2013 Jul 31, 2013 10-Q 2014-09-09
Q1 2013 -$16.1M -$5.28M -$2.67M -102% Feb 1, 2013 Apr 30, 2013 10-Q 2014-06-10
Q4 2012 -$13.4M -$5.71M -$1.34M -30.8% Nov 1, 2012 Jan 31, 2013 10-Q 2014-03-17
Q3 2012 -$12.1M -$1.99M +$888K +30.9% Aug 1, 2012 Oct 31, 2012 10-K 2014-01-29
Q2 2012 -$13M -$3.1M -$6.75M -185% May 1, 2012 Jul 31, 2012 10-Q 2013-09-16
Q1 2012 -$6.21M -$2.61M +$7.03M +72.9% Feb 1, 2012 Apr 30, 2012 10-Q 2013-06-14
Q4 2011 -$13.2M -$4.37M -$5.12M -677% Nov 1, 2011 Jan 31, 2012 10-Q/A 2013-03-25
Q3 2011 -$8.12M -$2.88M Aug 1, 2011 Oct 31, 2011 10-K 2014-01-29
Q2 2011 $3.64M +$1.59M +77.2% May 1, 2011 Jul 31, 2011 10-Q/A 2012-10-04
Q1 2011 -$9.64M Feb 1, 2011 Apr 30, 2011 10-Q/A 2012-10-18
Q4 2010 $757K Nov 1, 2010 Jan 31, 2011 10-Q/A 2012-10-18
Q2 2010 $2.06M May 1, 2010 Jul 31, 2010 10-Q 2011-09-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.